Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jill Marie Broadfoot currently holds 37,296 shares of aTYR PHARMA INC (LIFE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jill Marie Broadfoot has been a net buyer of LIFE stock. They have purchased $101.7K and sold $12.4K worth of shares.
Jill Marie Broadfoot's most recent insider trade was on Feb 4, 2026, when they sold 1,558 shares at $0.98 per share.
Jill Marie Broadfoot serves as Executive at aTYR PHARMA INC (LIFE). They have executed 33 insider transactions totaling $114.1K over their tenure at the company.
Jill Marie Broadfoot holds the position of Executive at aTYR PHARMA INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Jill Marie Broadfoot has shown a buying trading pattern, with $101.7K in total purchases and $12.4K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jill Marie Broadfoot was on Apr 1, 2013, when they sold $147.9K worth of VICL shares. This transaction involved 38,121 shares at $3.88 per share.
Jill Marie Broadfoot currently owns 37,296 shares of aTYR PHARMA INC (LIFE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jill Marie Broadfoot's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jill Marie Broadfoot has 33 Form 4 filings on record as an insider at aTYR PHARMA INC.
Set alerts for Jill Marie Broadfoot and 40,000+ other insiders.